1. Home
  2. News
  3. Invex Therapeutics Ltd.
  4. Invex Receives Regulatory Approval for IIH EVOLVE in France
More Invex Therapeutics Ltd. news
Invex Therapeutics Ltd.ASX: IXC

Invex Receives Regulatory Approval for IIH EVOLVE in France

Apr 20, 2023 at 10:38 PM EDT · Issued by Invex Therapeutics Ltd.

Filed with ASX · Apr 20, 2023 at 10:38 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/invex-receives-regulatory-approval-for-iih-evolve-in-france

Invex Therapeutics Ltd. on 6ix

Story so far

  • Israel Ministry of Health Approval for IIH EVOLVEApr 20, 2023
  • German Approval for IIH EVOLVE Phase 3 Clinical TrialMar 20, 2023
  • First US Clinical Site Activated in IIH EVOLVE Phase IIIJan 19, 2023

Earlier from Invex Therapeutics

  • Israel Ministry of Health Approval for IIH EVOLVEApr 19, 2023
  • German Approval for IIH EVOLVE Phase 3 Clinical TrialMar 19, 2023
  • Half Year AccountsFeb 16, 2023
  • First US Clinical Site Activated in IIH EVOLVE Phase IIIJan 18, 2023
  • Invex Receives Approval for Paediatric Plan from the EMADec 13, 2022

Later from Invex Therapeutics

  • Invex Granted European Orphan Drug Designation for TBIJun 22, 2023
  • Phase III Clinical Trial Update and New IIH Market AnalysisJun 27, 2023
  • Invex to close IIH Evolve Phase III Clinical TrialAug 20, 2023
  • Invex issued US patent for Traumatic Brain InjuryAug 23, 2023
  • Proposed Capital Return to Shareholders of $14.0 MillionNov 1, 2023
All Invex Therapeutics news releases↗

Follow Invex Therapeutics into a list and get an email when it puts out news.

Follow Invex Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer